CR20230265A - Formulación de polvo seco de muteína de lipocalina para el tratamiento del asma - Google Patents
Formulación de polvo seco de muteína de lipocalina para el tratamiento del asmaInfo
- Publication number
- CR20230265A CR20230265A CR20230265A CR20230265A CR20230265A CR 20230265 A CR20230265 A CR 20230265A CR 20230265 A CR20230265 A CR 20230265A CR 20230265 A CR20230265 A CR 20230265A CR 20230265 A CR20230265 A CR 20230265A
- Authority
- CR
- Costa Rica
- Prior art keywords
- dry powder
- powder formulation
- asthma
- lipocalin mutein
- treatment
- Prior art date
Links
- 102000019298 Lipocalin Human genes 0.000 title abstract 3
- 108050006654 Lipocalin Proteins 0.000 title abstract 3
- 238000009472 formulation Methods 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- 239000000843 powder Substances 0.000 title abstract 3
- 208000006673 asthma Diseases 0.000 title abstract 2
- 239000012634 fragment Substances 0.000 abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Otolaryngology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063127903P | 2020-12-18 | 2020-12-18 | |
| PCT/EP2021/086730 WO2022129629A1 (en) | 2020-12-18 | 2021-12-20 | Lipocalin mutein dry powder formulation for treatment of asthma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR20230265A true CR20230265A (es) | 2023-09-29 |
Family
ID=79686778
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR20230265A CR20230265A (es) | 2020-12-18 | 2021-12-20 | Formulación de polvo seco de muteína de lipocalina para el tratamiento del asma |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP4262845A1 (zh) |
| JP (1) | JP2023553703A (zh) |
| KR (1) | KR20230121785A (zh) |
| CN (1) | CN116916945A (zh) |
| AR (1) | AR124436A1 (zh) |
| AU (1) | AU2021399151A1 (zh) |
| CA (1) | CA3199479A1 (zh) |
| CL (1) | CL2023001775A1 (zh) |
| CO (1) | CO2023007904A2 (zh) |
| CR (1) | CR20230265A (zh) |
| IL (1) | IL303729A (zh) |
| MX (1) | MX2023007174A (zh) |
| PE (1) | PE20240799A1 (zh) |
| TW (1) | TW202241490A (zh) |
| WO (1) | WO2022129629A1 (zh) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003275958A1 (en) | 2003-08-25 | 2005-03-10 | Pieris Proteolab Ag | Muteins of tear lipocalin |
| JP5608368B2 (ja) | 2006-08-01 | 2014-10-15 | ピエリス アーゲー | 涙リポカリンの突然変異タンパク質およびそれを得るための方法 |
| NZ603562A (en) | 2010-06-08 | 2014-07-25 | Pieris Ag | Tear lipocalin muteins binding il-4 r alpha |
| HUE042720T2 (hu) | 2011-12-13 | 2019-07-29 | Pieris Pharmaceuticals Gmbh | Eljárás bizonyos rendellenességek megelõzésére vagy kezelésére IL-4 és/vagy IL-13 saját receptorához történõ kötõdésének gátlása révén |
| MA55490A (fr) | 2019-03-29 | 2022-02-09 | Astrazeneca Ab | Mutéine de lipocaline pour le traitement de l'asthme |
| CN113939307A (zh) * | 2019-03-29 | 2022-01-14 | 皮里斯制药有限公司 | 脂质运载蛋白突变蛋白的吸入施用 |
-
2021
- 2021-12-20 JP JP2023536889A patent/JP2023553703A/ja active Pending
- 2021-12-20 CN CN202180085274.3A patent/CN116916945A/zh active Pending
- 2021-12-20 WO PCT/EP2021/086730 patent/WO2022129629A1/en active Application Filing
- 2021-12-20 PE PE2023001901A patent/PE20240799A1/es unknown
- 2021-12-20 CR CR20230265A patent/CR20230265A/es unknown
- 2021-12-20 AR ARP210103583A patent/AR124436A1/es unknown
- 2021-12-20 MX MX2023007174A patent/MX2023007174A/es unknown
- 2021-12-20 TW TW110147707A patent/TW202241490A/zh unknown
- 2021-12-20 CA CA3199479A patent/CA3199479A1/en active Pending
- 2021-12-20 IL IL303729A patent/IL303729A/en unknown
- 2021-12-20 AU AU2021399151A patent/AU2021399151A1/en active Pending
- 2021-12-20 KR KR1020237023191A patent/KR20230121785A/ko unknown
- 2021-12-20 EP EP21844230.9A patent/EP4262845A1/en not_active Withdrawn
-
2023
- 2023-06-15 CL CL2023001775A patent/CL2023001775A1/es unknown
- 2023-06-16 CO CONC2023/0007904A patent/CO2023007904A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW202241490A (zh) | 2022-11-01 |
| PE20240799A1 (es) | 2024-04-18 |
| JP2023553703A (ja) | 2023-12-25 |
| EP4262845A1 (en) | 2023-10-25 |
| CA3199479A1 (en) | 2022-06-23 |
| AR124436A1 (es) | 2023-03-29 |
| KR20230121785A (ko) | 2023-08-21 |
| CN116916945A (zh) | 2023-10-20 |
| WO2022129629A1 (en) | 2022-06-23 |
| IL303729A (en) | 2023-08-01 |
| MX2023007174A (es) | 2023-09-08 |
| AU2021399151A1 (en) | 2023-07-27 |
| CL2023001775A1 (es) | 2024-01-19 |
| CO2023007904A2 (es) | 2023-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202103404B (en) | Composition and method for treating the lungs | |
| ATE369353T1 (de) | Medizinisch verwendbare arylethanolamin verbindungen | |
| MX369385B (es) | Productos para cicatrizar heridas tisulares. | |
| TW200630105A (en) | Herbal composition PHY906 and its use in chemotherapy | |
| PH12020500543A1 (en) | Nonracemic mixtures and uses thereof | |
| EA201291306A1 (ru) | Состав сухого порошка, содержащий антимускариновое средство | |
| EA201070129A1 (ru) | Фармацевтический сухой порошкообразный аэрозольный состав, включающий полипептид, и способ его приготовления | |
| MX2021014774A (es) | Formulaciones de liberacion modificada y usos de las mismas. | |
| JO3434B1 (ar) | مركبات صيدلانية لمعالجة السرطان وامراض واضطرابات اخري | |
| PH12020551911A1 (en) | Use of riluzole oral disintigrating tablets for treating diseases | |
| BR112021021195A2 (pt) | Métodos para tratamento ou prevenção da asma pela administração de um antagonista de il-33 | |
| PH12019501900A1 (en) | Treatment of hidradenitis suppurativa | |
| AU2020278236A8 (en) | Methods of treating Sjögren's Syndrome using a Bruton's tyrosine kinase inhibitor | |
| NO20073813L (no) | Kladribinregime for behandling av multippel sklerose | |
| MX2021001563A (es) | Uso de tabletas de desintegracion oral de riluzol para tratar enfermedades. | |
| MX2021002322A (es) | Nuevos metodos. | |
| MY145166A (en) | Novel tiotropium salts, process for the preparation and pharmaceutical compositions thereof | |
| MX2020010738A (es) | Formulaciones de ciclosporina para uso en el tratamiento del sindrome de bronquiolitis obliterante (bos). | |
| BR112023004020A2 (pt) | Métodos para tratamento de asma em indivíduos pediátricos através da administração de um antagonista de il-4r | |
| CR20230265A (es) | Formulación de polvo seco de muteína de lipocalina para el tratamiento del asma | |
| MX2015015150A (es) | Composiciones farmaceuticas inhalables y los dispositivos inhaladores que las contienen. | |
| MX2007005525A (es) | Tratamiento terapeutico de resorcion ose acelerada. | |
| SE0200657D0 (sv) | Novel Formulation | |
| IL250852B (en) | Periodontal preparation | |
| MX2021011491A (es) | Polvos secos inhalables. |